Bruker Launches Molecular Phenomics Research Tool for Long COVID Multi-Organ Risk Assessment
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Researchers have revealed how variants of a gene responsible for packing and condensing genetic material present a novel cause for certain neurodevelopmental disorders.
New research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Using a blood test, a research team has predicted the risk of Alzheimer’s disease in people who were clinically diagnosed as not having Alzheimer’s disease but who perceived themselves as cognitively impaired.
Read MoreUniversity of Birmingham Enterprise has filed a patent application covering the method and its use in diagnostic equipment, and is now seeking to license the patent for rapid product development.
Read MoreThe PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.
Read MoreNIH researchers developed two covid-19 assays to detect the spike protein and receptor binding protein, achieving sensitivity of 100% and specificity of 100% using the Mitra Microsampler from Neoteryx.
Read MoreUnder certain conditions, self-collected swabs may be a good alternative to nasopharyngeal swabs collected by health professionals for antigen testing.
Read MoreNew research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read MoreResearchers concluded that PixCell’s HemoScreen, a miniature, easy-to-use, AI and machine vision-enabled hematology analyzer, can fill the gap in point-of-care diagnostics.
Read MoreScientific sessions during the virtual 2020 AACC Meeting & Expo will highlight clinical laboratories’ integral role in managing the opioid epidemic and the latest drug tests needed to do so.
Read MoreResearchers gained significant insight into when covid-19 virus detection also may indicate contagiousness.
Read MoreNew data highlight the role of the test in further individualizing treatment decisions in early breast cancer.
Read MoreResearchers have found new forms of tau protein that become abnormal in the very early stages of Alzheimer’s disease before cognitive problems develop.
Read MoreResearchers say the controls have the potential to improve the accuracy of new covid-19 tests that are simpler, faster, and cheaper, making it possible to expand testing outside the lab.
Read MoreThe published map, which characterizes the genomic distributions of 5hmC in 19 human tissues, lays the foundation for the future development of diagnostic tests.
Read MoreThe rapid, one-step CRISPR-based mobile test could help combat the covid-19 pandemic and fully reopen communities.
Read MoreResults of standard laboratory tests performed on adult outpatients to provide an overall picture of their health are fairly consistent between those with obesity and their leaner counterparts, investigators report.
Read More